47
DAFTAR PUSTAKA
1. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.; 2014 Nov;11(11):639–54.
2. Go A, Hylek E, Phillips K. Prevalence of diagnosed atrial fibrillation in adults. JAMA J Am Med Assoc. 2001;285(18):9;285(18):2370–5.
3. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–429.
4. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.
5. Heeringa J. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2005;27(8):949–53.
6. Yuniadi Y, Tondas AE, Hanafy DA, Hermanto DY, Maharani E, Munawar M, et al. Pedoman Tata Laksana Fibrilasi Atrium. 1st ed. Centra Communications; 2014.
7. Ariansena I, Gjesdala K, Abdelnoorb M, Edvardsenc E, Engerd S, Tveitd A. Quality of Life , Exercise Capacity and Comorbidity in Old Patients with Permanent Atrial Fibrillation. J Atr Fibrillation. 2009;1(4):13–20.
8. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002 Oct;113(5):359–64.
10. Benjamin EJ D’Agostino RB, Silbershatz H, Kannel WB, Levy D WPA. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–52.
11. Hui DS, Morley JE, Mikolajczak PC, Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J. 2015;169(4):448–56.
12. Gaita F, Corsinovi L, Anselmino M, Raimondo C, Pianelli M, Toso E, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol. 2013;62(21):1990–7.
13. Thacker EL, McKnight B, Psaty BM, Longstreth WT, Sitlani CM, Dublin S, et al. Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology. 2013 Jul 9;81(2):119–25.
14. Marzona I, O’Donnell M, Teo K. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. Can Med Assoc J. 2012;184(6):E329–36.
15. Costa AS, Fimm B, Friesen P, Soundjock H, Rottschy C, Gross T, et al. Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dement Geriatr Cogn Disord. 2012;33(6):379–84.
16. Freitas S, Simões MR, Alves L, Vicente M, Santana I. Montreal Cognitive Assessment (MoCA): Validation Study for Vascular Dementia. J Int Neuropsychol Soc. 2012;1–10.
17. Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini–Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatrics. 2012;24(11):1749–55.
18. Salam S, Muis A, Aliah A, Akbar M. Association Atrial Fibrillation with Cognitive Fakultas Kedokteran Universitas Hasanuddin. 2013;0–12.
20. Nasution SA, Ranitya R, Ginanjar E. Fibrilasi Atrial. In: Buku Ajar Ilmu Penyakit Dalam. 6th ed. Interna Publishing; 2014. p. 1365–79.
21. Gehi AK, Mounsey PJ. Atrial Fibrillation. In: Netter’s Cardiology. 2nd ed. Elsevier Inc; 2010. p. 233–9.
22. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation. Circulation. 2006;114(7):700–52.
23. Jaïs P, Haïssaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95(3):572–6.
24. Takahashi Y, Hocini M, O’Neill MD, Sanders P, Rotter M, Rostock T, et al. Sites of focal atrial activity characterized by endocardial mapping during atrial fibrillation. J Am Coll Cardiol. 2006;47(10):2005–12.
25. Tse HF, Lau CP, Kou W, Pelosi F, Oral H, Kim M, et al. Prevalence and significance of exit block during arrhythmias arising in pulmonary veins. J Cardiovasc Electrophysiol. 2000;11(4):379–86.
26. Prystowsky EN, J. Padanilam B, L.Waldo A. Atrial Fibrillation, Atrial Flutter, and Atrial Tachycardia. In: Hurst’s The Heart. 13th ed. The McGraw-Hill Companies,Inc.; 2011. p. 963–86.
27. Morady F, P.Zipes D. Atrial Fibrillation: Clinical Features, Mechanisms, for atrial fibrillation: causes of “not-so-lone atrial fibrillation.” Europace. 2008;10(6):668–73.
diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost. 2011;106(6):1012–9.
31. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: Report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J. 2010;31(8):967–75.
32. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33(21):2719–47.
33. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby J V, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019–26.
34. Gillis AM, Verma A, Talajic M, Nattel S, Dorian P. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. Can J Cardiol. 2011;27:47–59.
35. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost. 2012;107(6):1172–9.
36. Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342(jan31 1):d124.
37. Friberg L, Rosenqvist M, Lip GYH. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33(12):1500–10.
39. Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, et al. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5(2):312–8.
40. Harris P, Nagy S, Vardaxis N. Mosby’s Dictionary of Medicine, Nursing and Health Professions. Training. 2010. 2072 p.
41. Glisky EL. Changes in Cognitive Function in Human Aging. CRC Press/Taylor & Francis; 2007.
42. Zabar Y, Danay P, Macaulay C. Cognitive and Language Evaluation. In: Netter’s Neurology. 2nd ed. Elsevier Inc; 2011. p. 31–50.
43. Satyanegara. Ilmu Bedah Saraf Satyanegara. 4th ed. Gramedia Pustaka Utama; 2010.
44. Nolen-Hoeksema S, Fredrickson B, Loftus G. Atkinson & Hilgard’s Introduction to Psychology. Cengage Learning. 2009. 800 p.
45. Ropper AH, Samuels MA, Klein JP. Dementia, the Amnestic Syndrome, and the Neurology of Intelligence and Memory. In: Adams & Victor’s Principles of Neurology. 10th ed. McGraw-Hill; 2014. p. 434–54.
46. Zabar Y. Dementia: Mild Cognitive Impairment, Alzheimer Disease, Lewy Body Dementia, Frontotemporal Lobar Dementia, Vascular Dementia. In: Netter’s Neurology. 2nd ed. Elsevier Inc.; 2011. p. 219–43.
47. About | MoCA Montreal - Cognitive Assessment [Internet]. [cited 2016 Jan 9]. Available from: http://www.mocatest.org/
48. Shea S, Di Tullio M. Atrial fibrillation, silent cerebral ischemia, and cognitive function. J Am Coll Cardiol. Elsevier Inc; 2013;62(21):1998–9.
50. Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane PK, et al. Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci. 2014;69(5):609–15.
51. Duron E, Hanon O. Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag. 2008;4(2):363–81.
52. O’Sullivan M. Leukoaraiosis. Pract Neurol. 2008;8(1):26–38.
53. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998;55(11):1475–82.
54. Lip GYH, Bawden L, Hodson R, Rutland E, Snatchfold J, Beevers DG. Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project. Int J Cardiol. 1998;65(2):187–92.
55. Ball J, Carrington MJ, Stewart S. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart. 2013;99(8):542–7.
56. Wadley VG, McClure LA, Howard VJ, Unverzagt FW, Go RC, Moy CS, et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke. 2007;38(4):1143–7.
57. Alosco ML, Spitznagel MB, Sweet LH, Josephson R, Hughes J, Gunstad J. Atrial fibrillation exacerbates cognitive dysfunction and cerebral perfusion in heart failure. PACE - Pacing Clin Electrophysiol. 2015;38(2):178–86.
Lampiran 5. Data Subjek Penelitian
No Nama Jenis Kelamin
Umur Pendidikan Terakhir
Lampiran 6. Uji Statistik SPSS
JenisKelamin
Frequency Percent Valid Percent Cumulative
Percent
Frequency Percent Valid Percent Cumulative
Pendidikan * Status Crosstabulation
Continuity Correctionb 11,813 1 ,001
Likelihood Ratio 16,490 1 ,000
Fisher's Exact Test ,000 ,000
Linear-by-Linear Association 14,063 1 ,000
N of Valid Cases 28
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,00.
Risk Estimate
Value 95% Confidence Interval
Lower Upper
Odds Ratio for Status
(Sinus / Fibrilasi Atrium)
47,667 4,318 526,168
For cohort Intepretasi =
Normal
11,000 1,632 74,164
For cohort Intepretasi =
Menurun
,231 ,084 ,636
Lampiran 7. Biodata Mahasiswa
Identitas
Nama : Rofat Askoro Bimandoko NIM : 22010112130204
Tempat/tanggal lahir : Jakarta / 22 April 1995 Jenis kelamin : Laki-Laki
Alamat : Jalan Platuk Bawang, No.15, Kerten, Laweyan, Surakarta Nomor HP : 081804453222
e-mail : [email protected]
Riwayat Pendidikan Formal
